Skip to main content

letter

. 2013 Apr 5;25(6):449–451. [Article in Spanish] doi: 10.1016/S0212-6567(00)78542-8

Neuropatía periférica y amiodarona

P Schwartz Calero ^a, J Torelló Iserte ^b, E Giner Calzada ^c, A Cuder Ambel ^a

PMCID: PMC7675792

The content is available as a PDF (60.2 KB).

Bibliografía

1.Martindale P.C. Pharmaceutical Press; Massachusetts:: 1999. The complete drug reference; pp. 820–822. [Google Scholar]
2.USP D.I. Micromedex; Massachusetts:: 1999. Drug information for the health professionals; pp. 79–85. [Google Scholar]
3.Roth R.F., Itabashi H., Louie J., Anderson T., Narahara K.A. Amiodarone toxicity: myopathy and neuropathy. Am Heart J. 1990:1223–1225. doi: 10.1016/s0002-8703(05)80264-9. [DOI] [PubMed] [Google Scholar]
4.Martínez-Arizala A., Sobol S.M., Mc-Carty G.E., Nichols B.R., Rakita L. Amiodarone neuropathy. Neurology. 1983;33:643–645. doi: 10.1212/wnl.33.5.643. [DOI] [PubMed] [Google Scholar]
5.Tamargo J., Valenzuela C. Fármacos antiarrítmicos. In: Florez J., editor. Farmacología humana. Masson; Barcelona:: 1997. pp. 649–669. [Google Scholar]
6.Stockley I.H. Blackwell Scientific Pub; Oxford:: 1994. Drug interactions. [Google Scholar]

ACTIONS

RESOURCES